JP2009502114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502114A5 JP2009502114A5 JP2008503309A JP2008503309A JP2009502114A5 JP 2009502114 A5 JP2009502114 A5 JP 2009502114A5 JP 2008503309 A JP2008503309 A JP 2008503309A JP 2008503309 A JP2008503309 A JP 2008503309A JP 2009502114 A5 JP2009502114 A5 JP 2009502114A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- amino acid
- acid sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 42
- 102000004196 processed proteins & peptides Human genes 0.000 claims 42
- 108090000765 processed proteins & peptides Proteins 0.000 claims 42
- 125000003275 alpha amino acid group Chemical group 0.000 claims 30
- 108091033319 polynucleotide Proteins 0.000 claims 21
- 239000002157 polynucleotide Substances 0.000 claims 21
- 102000040430 polynucleotide Human genes 0.000 claims 21
- 230000004071 biological effect Effects 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 17
- 230000000694 effects Effects 0.000 claims 15
- 239000002773 nucleotide Substances 0.000 claims 14
- 125000003729 nucleotide group Chemical group 0.000 claims 14
- 238000000034 method Methods 0.000 claims 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims 12
- 229930195729 fatty acid Natural products 0.000 claims 12
- 239000000194 fatty acid Substances 0.000 claims 12
- 150000004665 fatty acids Chemical group 0.000 claims 12
- 206010060862 Prostate cancer Diseases 0.000 claims 10
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 10
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 108091028664 Ribonucleotide Proteins 0.000 claims 9
- 108091081021 Sense strand Proteins 0.000 claims 9
- 239000002336 ribonucleotide Substances 0.000 claims 9
- 125000002652 ribonucleotide group Chemical group 0.000 claims 9
- 230000000692 anti-sense effect Effects 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 239000013598 vector Substances 0.000 claims 5
- 108700008625 Reporter Genes Proteins 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 108020004459 Small interfering RNA Proteins 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims 2
- 239000004055 small Interfering RNA Substances 0.000 claims 2
- 101150032050 ELOVL7 gene Proteins 0.000 claims 1
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 claims 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 230000027455 binding Effects 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 229940039227 diagnostic agent Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70310705P | 2005-07-27 | 2005-07-27 | |
| PCT/JP2006/314714 WO2007013479A2 (en) | 2005-07-27 | 2006-07-19 | Genes and polypeptides relating to prostate cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009502114A JP2009502114A (ja) | 2009-01-29 |
| JP2009502114A5 true JP2009502114A5 (https=) | 2009-09-03 |
Family
ID=37198855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008503309A Pending JP2009502114A (ja) | 2005-07-27 | 2006-07-19 | 前立腺癌に関連する遺伝子およびポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8067153B2 (https=) |
| EP (2) | EP1907859B1 (https=) |
| JP (1) | JP2009502114A (https=) |
| CN (1) | CN101273271A (https=) |
| DE (1) | DE602006020451D1 (https=) |
| WO (1) | WO2007013479A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101855346A (zh) * | 2007-08-24 | 2010-10-06 | 肿瘤疗法科学股份有限公司 | Pkib和naaladl2用作前列腺癌治疗和诊断的靶基因 |
| US8420329B2 (en) | 2008-11-20 | 2013-04-16 | Oncotherapy Science, Inc. | Methods for diagnosing or treating prostate cancer |
| TW201032820A (en) * | 2008-12-16 | 2010-09-16 | Oncotherapy Science Inc | ELOVL7 epitope peptides and vaccines containing the same |
| GB201016139D0 (en) * | 2010-09-24 | 2010-11-10 | Univ Leuven Kath | Cancer phosholipidome |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| WO1993002227A1 (en) | 1991-07-15 | 1993-02-04 | Eco-Tec Limited | Process and apparatus for treating fluoride containing acid solutions |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| US5285485A (en) | 1993-02-01 | 1994-02-08 | General Electric Company | Composite nuclear fuel container and method for producing same |
| JPH08509612A (ja) | 1993-04-26 | 1996-10-15 | ジェンファーム インターナショナル インコーポレイテッド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US20020103360A1 (en) | 1998-09-01 | 2002-08-01 | Yang Pan | Novel protein related to melanoma-inhibiting protein and uses thereof |
| EP1341920A2 (en) * | 2000-11-29 | 2003-09-10 | Xenon Genetics, Inc. | Human elongase genes and uses thereof |
| AU2002231779A1 (en) * | 2001-02-09 | 2002-08-28 | Bayer Aktiengesellschaft | Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| WO2003009814A2 (en) * | 2001-07-25 | 2003-02-06 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| TW200413539A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Genes and polypeptides relating to prostate cancers |
| US7250496B2 (en) | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
-
2006
- 2006-07-19 US US11/913,233 patent/US8067153B2/en not_active Expired - Fee Related
- 2006-07-19 WO PCT/JP2006/314714 patent/WO2007013479A2/en not_active Ceased
- 2006-07-19 CN CNA2006800356575A patent/CN101273271A/zh active Pending
- 2006-07-19 EP EP06781626A patent/EP1907859B1/en not_active Not-in-force
- 2006-07-19 JP JP2008503309A patent/JP2009502114A/ja active Pending
- 2006-07-19 EP EP10196492A patent/EP2336780A1/en not_active Withdrawn
- 2006-07-19 DE DE602006020451T patent/DE602006020451D1/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008532477A5 (https=) | ||
| JP2009502115A5 (https=) | ||
| Hall et al. | Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets | |
| JP2012135301A5 (https=) | ||
| ES2837437T3 (es) | Usos diagnósticos, pronósticos y terapéuticos de ARN largos no codificantes para cardiopatías y medicina regenerativa | |
| EP2516647B1 (en) | Molecule for treating an inflammatory disorder | |
| CN103290009B (zh) | 具有促进iNOS mRNA的分解的NO产生抑制活性的正义寡核苷酸以及iNOS产生量的抑制方法 | |
| JP2012501164A5 (https=) | ||
| JP2002272489A5 (https=) | ||
| JP2006518186A5 (https=) | ||
| JP2005534295A5 (https=) | ||
| JP2005511023A5 (https=) | ||
| CN107586850B (zh) | 非编码基因在肝癌诊疗中的应用 | |
| US20090221435A1 (en) | Microarray for detecting and quantifying microrna | |
| CN113584027B (zh) | 一种激活p21基因表达的方法 | |
| JP2009505633A5 (https=) | ||
| JP2009502114A5 (https=) | ||
| JP2007530431A5 (https=) | ||
| RU2011111551A (ru) | C12orf48 как ген-мишень для лечения и диагностики рака | |
| JP2014523736A5 (https=) | ||
| TWI448553B (zh) | 基因產物之產生量控制方法及產生量控制劑 | |
| Imamura et al. | A peptide nucleic acid to reduce type I collagen production by fibroblast cells | |
| CN107227362B (zh) | 一种与肝癌相关的基因及其应用 | |
| CN113924364A (zh) | 治疗亨廷顿病的组合物和方法 | |
| JPWO2014112144A1 (ja) | 染色体セントロメア由来のサテライトノンコーディングｒｎａを標的とした核酸抗癌剤、及び該抗癌剤を用いる方法 |